期刊文献+

青中年冠心病患者代谢综合征危险因素的分布与聚集状况分析 被引量:10

Distribution of metabolic syndrome in young and middle age patients with coronary artery disease
原文传递
导出
摘要 目的分析青中年冠心病患者中代谢综合征(MS)危险因素的分布与聚集状况,为早期防治干预提供依据。方法对103例青中年男性[年龄30~50(43.3±5.7)岁]冠心病患者及64例男性[年龄28~50(42.8±6.3)岁]冠状动脉造影正常的对照组的临床特征和生化特点进行比较。按照中华医学会糖尿病学分会标准诊断MS。结果两组在年龄上无差异。冠心病组的吸烟率显著高于对照组,但在冠心病家族史方面两组无差异。冠心病组的总胆固醇(TC)、餐后2h血糖(2hPBG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMAIR)均显著高于对照组,而HDLC显著低于后者。冠心病组MS的发生率显著高于对照组(P<0.01)。Logistic回归分析显示,吸烟、低HDLC、HOMAIR、MS使青中年人冠心病患病的相对危险度增加。结论青中年冠心病患者多种代谢异常更加严重,对于青中年男性应重视MS的预防,以减少心血管事件的发生。 Objective:To study the distribution of metabolic syndrome in young and middle age patients with coronary artery disease. Method:One hundred and three young and middle age men with coronary artery disease(CAD) and 64 cases age matched men were retrospectively studied. All of them underwent selective coronary angiography.Result:As compared with the group of control, patients with CAD showed higher TC, 2 h PBG,FINS,HOMA-IR,and lower HDL-C values. According to CDS standard, they also had high frequencies of metabolic syndrome(MS), accounting for 48.5%. Multiple logistic regression analysis showed that close relationships exist between CAD and smoking ( OR =2.123), lower HDL-C( OR =1.115), HOMA-IR( OR =1.735), MS( OR =2.542). Conclusion:Metabolic syndrome is common in young and middle age patients with CAD. It is necessary to control multiple risk factors in order to prevent cardiovascular event.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第7期387-389,共3页 Journal of Clinical Cardiology
关键词 冠状动脉疾病 代谢综合征 脂蛋白类 高密度脂蛋白胆固醇 胰岛素抵抗 危险因素 Coronary disease Metabolic syndrome Lipoproteins,high-density lipoprotein cholesterol Insulin resistance Risk factor
  • 相关文献

参考文献5

  • 1Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24:683-689.
  • 2中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3041
  • 3Solymoss B C, Bourassa M G, Lesperance J, et al. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Coron Artery Dis, 2003 ,14:207-212.
  • 4Sacks F M. The role of high-density lipoprotein(HDL)cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol, 2002, 90: 139-143.
  • 5Scott M G. Hypertriglyceridemia, insulin resistance,and the metabolic syndrome. Am J Cardiol, 1999, 83:25-29.

二级参考文献3

共引文献3040

同被引文献60

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部